The PERPRISE study (Study 509; NCT04202159) was a prospective, observational, non‐interventional study in a real‐world setting in Germany. This study was conducted to evaluate the effectiveness of perampanel as the… Click to show full abstract
The PERPRISE study (Study 509; NCT04202159) was a prospective, observational, non‐interventional study in a real‐world setting in Germany. This study was conducted to evaluate the effectiveness of perampanel as the only adjunctive treatment for 12 months in patients aged ≥18 years with focal to bilateral tonic–clonic seizures (FBTCS) or generalized tonic–clonic seizures (GTCS) in clinical practice.
Keywords:
germany;
perprise study;
effectiveness perampanel;
perampanel adjunctive;
study
Journal Title: Epilepsia Open
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Epilepsia Open
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!